Lupus kliniske forsøg i Iowa
6 studier for Lupus søger deltagere på steder i Iowa.
Byer i Iowa
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50319, Iowa City
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Iowa City
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 15. sep. 2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of Iowa, Iowa City
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 28. aug. 2026 · NCT06925542Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Univeristy of Iowa, Iowa City
Rekrutterer
Alder 18 til 100 · Alle køn · Opdateret 10. aug. 2026 · NCT07180537A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- University of Iowa, Iowa City
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 5. jun. 2026 · NCT06613360Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.